Stroke biomarkers – the search for a rapid predictive test
This article was originally published in Clinica
Executive Summary
Stroke is the third leading cause of death in the US, and its cost to the country's healthcare system totalled $68.9bn in 2009, according to the American Heart Association. Timely and accurate diagnosis of stroke is critical to improving treatment. In this article, Phil Greenfield reports on the progress made in stroke biomarker research and the development of a truly predictive, rapid blood test